| HCC | Hepatocellular carcinoma |
| PLC | Primary liver cancer |
| HBV | Hepatitis B virus |
| HCV | Hepatitis C virus |
| NAFLD | Non-alcoholic fatty liver disease |
| cHCC-CCA | Combined hepatocellular–cholangiocarcinoma |
| CCA | Cholangiocarcinoma |
| K19 | Keratin 19 |
| K19+ | Keratin 19 positive |
| K19− | Keratin 19 negative |
| YAP | Yes-associated protein 1 |
| WWTR1 | WW domain-containing transcription regulator protein 1 |
| TAZ | Transcriptional co-activator with PDZ-binding motif |
| MST1/2 | STE20-like protein kinases 1/2 |
| LATS1/2 | Large tumor suppressor 1/2 |
| Sav1 | Salvador 1 |
| MOB1A/B | Mob kinase activator 1A |
| DFS | Disease-free survival |
| OS | Overall survival |
| ASH | Alcoholic steatohepatitis |
| NASH | Nonalcoholic steatohepatitis |
| PBC | Primary biliary cholangitis |